Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

This study has been completed.

Study NCT00297713 Information provided by Altus Pharmaceuticals

First Received: February 27, 2006 Last Updated: December 11, 2006 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	June 2006
Estimated Primary Completion Date:	No date given